4.8 Article

Altered antisense-to-sense transcript ratios in breast cancer

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1010559107

Keywords

-

Funding

  1. Novartis Pharmaceuticals, Inc.
  2. National Cancer Institute [CA89393]
  3. Department of Defense [W81XWH-07-1-0294]
  4. Avon Foundation
  5. Breast Cancer Research Foundation
  6. Susan G. Komen Foundation
  7. Terri Brodeur Breast Cancer Foundation

Ask authors/readers for more resources

Transcriptome profiling studies suggest that a large fraction of the genome is transcribed and many transcripts function independent of their protein coding potential. The relevance of noncoding RNAs (ncRNAs) in normal physiological processes and in tumorigenesis is increasingly recognized. Here, we describe consistent and significant differences in the distribution of sense and antisense transcripts between normal and neoplastic breast tissues. Many of the differentially expressed antisense transcripts likely represent long ncRNAs. A subset of genes that mainly generate antisense transcripts in normal but not cancer cells is involved in essential metabolic processes. These findings suggest fundamental differences in global RNA regulation between normal and cancer cells that might play a role in tumorigenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available